chitosan has been researched along with Cross Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, M; Ali, ANM; Hussein, NH; Kadmy, IMSA; Khazaal, SS; Muslim, SN; Salman, BK | 1 |
| Cui, F; Huang, J; Huang, Q; Li, G; Lu, M; Lu, W; Zhang, J | 1 |
2 other study(ies) available for chitosan and Cross Infection
| Article | Year |
|---|---|
Chitosan extracted from Aspergillus flavus shows synergistic effect, eases quorum sensing mediated virulence factors and biofilm against nosocomial pathogen Pseudomonas aeruginosa.
Topics: Aspergillus flavus; Bacterial Proteins; Biofilms; Chitosan; Cross Infection; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Quorum Sensing; Trans-Activators | 2018 |
Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream.
Topics: Administration, Intranasal; Animals; Anti-Infective Agents, Local; Chemistry, Pharmaceutical; Chitosan; Cross Infection; Drug Delivery Systems; Emulsions; Humans; Lysostaphin; Materials Testing; Mice; Mice, Nude; Microbial Sensitivity Tests; Mucociliary Clearance; Nasal Mucosa; Ointment Bases; Petrolatum; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus | 2010 |